These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1038 related items for PubMed ID: 27160717

  • 41. Metyrapone treatment in Cushing's syndrome: a real-life study.
    Ceccato F, Zilio M, Barbot M, Albiger N, Antonelli G, Plebani M, Watutantrige-Fernando S, Sabbadin C, Boscaro M, Scaroni C.
    Endocrine; 2018 Dec; 62(3):701-711. PubMed ID: 30014438
    [Abstract] [Full Text] [Related]

  • 42. Cortisol Measurements in Cushing's Syndrome: Immunoassay or Mass Spectrometry?
    Casals G, Hanzu FA.
    Ann Lab Med; 2020 Jul; 40(4):285-296. PubMed ID: 32067427
    [Abstract] [Full Text] [Related]

  • 43. Clinical laboratory findings and results of therapy in 55 patients with Cushing's syndrome.
    Erem C, Algün E, Ozbey N, Azezli A, Aral F, Orhan Y, Molvalilar S, Sencer E.
    J Endocrinol Invest; 2003 Jan; 26(1):65-72. PubMed ID: 12602537
    [Abstract] [Full Text] [Related]

  • 44. Diagnosis and management of Cushing's syndrome: results of an Italian multicentre study. Study Group of the Italian Society of Endocrinology on the Pathophysiology of the Hypothalamic-Pituitary-Adrenal Axis.
    Invitti C, Pecori Giraldi F, de Martin M, Cavagnini F.
    J Clin Endocrinol Metab; 1999 Feb; 84(2):440-8. PubMed ID: 10022398
    [Abstract] [Full Text] [Related]

  • 45. Elevated late-night salivary cortisol levels in elderly male type 2 diabetic veterans.
    Liu H, Bravata DM, Cabaccan J, Raff H, Ryzen E.
    Clin Endocrinol (Oxf); 2005 Dec; 63(6):642-9. PubMed ID: 16343098
    [Abstract] [Full Text] [Related]

  • 46. Late-night salivary cortisol measurement in the diagnosis of Cushing's syndrome.
    Carroll T, Raff H, Findling JW.
    Nat Clin Pract Endocrinol Metab; 2008 Jun; 4(6):344-50. PubMed ID: 18446140
    [Abstract] [Full Text] [Related]

  • 47. Late-night salivary cortisol as a screening test for the diagnosis of Cushing's syndrome in Japan.
    Doi M, Sekizawa N, Tani Y, Tsuchiya K, Kouyama R, Tateno T, Izumiyama H, Yoshimoto T, Hirata Y.
    Endocr J; 2008 Mar; 55(1):121-6. PubMed ID: 18202529
    [Abstract] [Full Text] [Related]

  • 48. Performance of LC-MS/MS and immunoassay based 24-h urine free cortisol in the diagnosis of Cushing's syndrome.
    Oßwald A, Wang R, Beuschlein F, Hartmann MF, Wudy SA, Bidlingmaier M, Zopp S, Reincke M, Ritzel K.
    J Steroid Biochem Mol Biol; 2019 Jun; 190():193-197. PubMed ID: 30959155
    [Abstract] [Full Text] [Related]

  • 49. UTILITY OF A SINGLE LATE-NIGHT PLASMA CORTISOL AND ACTH FOR THE DIAGNOSIS OF CUSHING SYNDROME.
    Jarial KDS, Bhansali A, Mukherjee KK, Pal R, Sharma A, Vashishtha RK, Sukumar SP, Sachdeva N, Walia R.
    Endocr Pract; 2018 Feb; 24(2):156-162. PubMed ID: 29144801
    [Abstract] [Full Text] [Related]

  • 50. Is late-night salivary cortisol a better screening test for possible cortisol excess than standard screening tests in obese patients with Type 2 diabetes?
    Ellis E, Chin PK, Hunt PJ, Lunt H, Lewis JG, Soule SG.
    N Z Med J; 2012 Apr 20; 125(1353):47-58. PubMed ID: 22522271
    [Abstract] [Full Text] [Related]

  • 51. Late-night salivary cortisol for diagnosis of Cushing's syndrome by liquid chromatography/tandem mass spectrometry assay.
    Erickson D, Singh RJ, Sathananthan A, Vella A, Bryant SC.
    Clin Endocrinol (Oxf); 2012 Apr 20; 76(4):467-72. PubMed ID: 21955126
    [Abstract] [Full Text] [Related]

  • 52. The diagnostic utility of late night salivary cortisol (LNSF) and cortisone (LNSE) in Cushing's syndrome.
    Garrahy A, Forde H, O'Kelly P, McGurren K, Zia-Ul-Hussnain HM, Noctor E, Tormey WP, Smith D, Dennedy MC, Bell M, Javadpour M, Agha A.
    Ir J Med Sci; 2021 May 20; 190(2):615-623. PubMed ID: 32803648
    [Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55. Overnight urinary free cortisol determination: a screening test for the diagnosis of Cushing's syndrome.
    Corcuff JB, Tabarin A, Rashedi M, Duclos M, Roger P, Ducassou D.
    Clin Endocrinol (Oxf); 1998 Apr 20; 48(4):503-8. PubMed ID: 9640418
    [Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58. Overnight dexamethasone suppression test: comparison of plasma and salivary cortisol measurement for the screening of Cushing's syndrome.
    Barrou Z, Guiban D, Maroufi A, Fournier C, Dugué MA, Luton JP, Thomopoulos P.
    Eur J Endocrinol; 1996 Jan 20; 134(1):93-6. PubMed ID: 8590965
    [Abstract] [Full Text] [Related]

  • 59. Diagnostic tests for Cushing's syndrome differ from published guidelines: data from ERCUSYN.
    Valassi E, Franz H, Brue T, Feelders RA, Netea-Maier R, Tsagarakis S, Webb SM, Yaneva M, Reincke M, Droste M, Komerdus I, Maiter D, Kastelan D, Chanson P, Pfeifer M, Strasburger CJ, Tóth M, Chabre O, Tabarin A, Krsek M, Fajardo C, Bolanowski M, Santos A, Wass JAH, Trainer PJ, ERCUSYN Study Group.
    Eur J Endocrinol; 2017 May 20; 176(5):613-624. PubMed ID: 28377460
    [Abstract] [Full Text] [Related]

  • 60. Salivary cortisol and cortisone by LC-MS/MS: validation, reference intervals and diagnostic accuracy in Cushing's syndrome.
    Antonelli G, Ceccato F, Artusi C, Marinova M, Plebani M.
    Clin Chim Acta; 2015 Dec 07; 451(Pt B):247-51. PubMed ID: 26449783
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 52.